Cardan Capital Partners’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Cardan Capital Partners’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$194K	Buy	+15,655	New	+$177K	0.02%	243

Other funds holding SLGC

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cardan Capital Partners's SLGC Position: Q3 2021 in Review

Cardan Capital Partners opened a new position in SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2021: 15,655 shares worth $194K. The stake represents 0.02% of the portfolio and ranks #243 among its holdings.

86 funds tracked by Wall St. Rank hold SLGC as of Q3 2021.

Cardan Capital Partners held 15,655 shares of SomaLogic, Inc. Class A Common Stock worth $194K as of Q3 2021.
SomaLogic, Inc. Class A Common Stock was a new Cardan Capital Partners position in Q3 2021.
SomaLogic, Inc. Class A Common Stock made up 0.02% of Cardan Capital Partners's portfolio in Q3 2021, its #243 holding.
86 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.